Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$42.5B |
| 2 |
NVIDIA
NVDA
|
+$2.39B |
| 3 |
Walmart Inc
WMT
|
+$1.17B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 5 |
JPMorgan Chase
JPM
|
+$808M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Amazon
AMZN
|
+$843M |
| 3 |
Xcel Energy
XEL
|
+$674M |
| 4 |
Global Payments
GPN
|
+$623M |
| 5 |
Palantir
PLTR
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.22% |
| 2 | Technology | 18.11% |
| 3 | Financials | 7.1% |
| 4 | Communication Services | 5.53% |
| 5 | Consumer Discretionary | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3176
Stratasys
SSYS
$763M
| $482K | ﹤0.01% |
61,745
+15,706
| +34% | +$154K |
2013 Q4
49 quarters
|
|
3177
BayCom
BCML
$341M
| $482K | ﹤0.01% |
16,199
-13,549
| -46% | -$399K |
2018 Q2
31 quarters
|
|
3178
Haverty Furniture Companies
HVT
$430M
| $481K | ﹤0.01% |
22,689
-19,379
| -46% | -$472K |
2016 Q2
39 quarters
|
|
3179
Bank of N.T. Butterfield & Son
NTB
$2.29B
| $479K | ﹤0.01% |
9,128
-55,856
| -86% | -$2.87M |
2017 Q1
36 quarters
|
|
3180
Verastem
VSTM
$692M
| $479K | ﹤0.01% |
90,300
-111,545
| -55% | -$688K |
2020 Q2
23 quarters
|
|
3181
Albany International
AIN
$1.72B
| $478K | ﹤0.01% |
9,154
-41,135
| -82% | -$2.31M |
2016 Q1
40 quarters
|
|
3182
Silvercrest Asset Management
SAMG
$82.4M
| $477K | ﹤0.01% |
35,473
-10,416
| -23% | -$155K |
2019 Q1
28 quarters
|
|
|
CBK
3183
Commercial Bancgroup
CBK
$435M
| $476K | ﹤0.01% |
18,280
+7,394
| +68% | +$190K |
2025 Q4
1 quarter
|
|
|
SLDE
3184
Slide Insurance Holdings
SLDE
$2.76B
| $475K | ﹤0.01% |
26,376
-278,602
| -91% | -$4.88M |
2025 Q2
3 quarters
|
|
3185
Omeros
OMER
$1.33B
| $474K | ﹤0.01% |
44,922
-75,568
| -63% | -$890K |
2013 Q2
51 quarters
|
|
3186
CVR Energy
CVI
$5.51B
| $474K | ﹤0.01% |
14,087
-40,660
| -74% | -$1.05M |
2013 Q2
51 quarters
|
|
3187
Sunstone Hotel Investors
SHO
$2.12B
| $474K | ﹤0.01% |
52,603
-256,040
| -83% | -$2.35M |
2013 Q2
51 quarters
|
|
3188
Spire Global
SPIR
$440M
| $473K | ﹤0.01% |
37,630
-5,154
| -12% | -$55.1K |
2024 Q2
7 quarters
|
|
3189
Immix Biopharma
IMMX
$798M
| $472K | ﹤0.01% |
51,768
+16,768
| +48% | +$123K |
2025 Q4
1 quarter
|
|
3190
Recursion Pharmaceuticals
RXRX
$2.18B
| $471K | ﹤0.01% |
153,271
-1,315,991
| -90% | -$5.09M |
2022 Q1
16 quarters
|
|
3191
Cooper-Standard Automotive
CPS
$391M
| $469K | ﹤0.01% |
16,842
-22,171
| -57% | -$742K |
2014 Q1
48 quarters
|
|
|
BFS
3192
Saul Centers
BFS
$745M
| $469K | ﹤0.01% |
14,404
-16,812
| -54% | -$557K |
2013 Q2
51 quarters
|
|
3193
Alerus Financial
ALRS
$808M
| $468K | ﹤0.01% |
19,740
-31,543
| -62% | -$765K |
2019 Q4
25 quarters
|
|
3194
Minerals Technologies
MTX
$2.07B
| $467K | ﹤0.01% |
6,578
-44,401
| -87% | -$3.05M |
2013 Q2
51 quarters
|
|
3195
PUT
Doximity
DOCS
$5.04B
| $466K | ﹤0.01% |
20,000
| – | – |
2025 Q4
1 quarter
|
|
3196
Taylor Devices
TAYD
$175M
| $466K | ﹤0.01% |
8,172
+4,639
| +131% | +$357K |
2024 Q2
7 quarters
|
|
3197
Microvast
MVST
$250M
| $466K | ﹤0.01% |
310,476
-164,592
| -35% | -$396K |
2022 Q1
16 quarters
|
|
3198
Schrodinger
SDGR
$2.29B
| $464K | ﹤0.01% |
40,878
-70,493
| -63% | -$974K |
2022 Q1
16 quarters
|
|
|
DHC
3199
Diversified Healthcare Trust
DHC
$1.88B
| $464K | ﹤0.01% |
69,899
-334,139
| -83% | -$2.12M |
2022 Q1
16 quarters
|
|
3200
Enliven Therapeutics
ELVN
$3.38B
| $464K | ﹤0.01% |
11,830
-58,045
| -83% | -$1.61M |
2023 Q1
12 quarters
|
|
Similar funds
Barclays's Q1 2026 Portfolio in Review
As of Q1 2026, Barclays held 5,572 positions worth $416B, down 0.11% from $417B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $42.4B of net new capital in Q1 2026, opening 397 new positions and adding to 1,219 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 44% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Tesla, an estimated $1.26B trimmed.
- Barclays's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q1 2026, an estimated $42.5B increase.
- Barclays's biggest Q1 2026 reduction was Tesla, cutting an estimated $1.26B.
- Barclays fully exited CyberArk in Q1 2026, selling an estimated $232M.
- Barclays's ten largest holdings make up 37% of its $416B portfolio in Q1 2026.
- Barclays opened 397 new positions and closed 563 in Q1 2026.
- Barclays's portfolio value fell 0.11% quarter-over-quarter to $416B.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.